Seeking Alpha

Watson Pharmaceuticals Inc. (WPI)

()

News & PR
Market Currents

Buzz
Twitter: WPI

Business Intelligence
Transcripts
Events
Key Developments

Instablog posts on WPI

Best and Worst International ETFs in 2009 by Moby Waller
International ETFs have exploded in popularity, largely due to the fact that they make it relatively easy for an individual investor to trade a singe focused country or region. Remember, however, that ETFs differ from each other, sometimes in huge ways, so be sure to investigate the... More »
November 6, 2009 • RSX, EWZ, WPI
Kendle International Healthcare by Michael Michaud
The Market Last Week and AheadFirst, the most important date report in the financial universe, the US Non-Farm Payroll Report is Friday. Last Friday authorities seized nine US banks. If people continue to carry trade the dollar and if they start to unwind those trades more traders and investors... More »
November 2, 2009 • KNDL, CVD, PRXL
Fast Money Final Trade for 9-1-09 by Market Fisher
Guy Adami suggests long Medco Health (MHS). (Click here to see Fast Money's interview with Medco CEO David Snow.)Joe Terranova says, “I’ve talked about being short Essex Property (ESS) but I’ve taken off 80% of my short position.Pete Najarian thinks Watson (WPI) is a buy.... More »
September 1, 2009 • MHS, ESS, WPI
TEVA: Predictable Growth - Good Value by Chuck Carnevale
HistoryConventional wisdom would indicate that finding a sure thing in the stock market is an impractical dream. However, Teva Pharmaceutical Industries, Ltd. (TEVA) may be as close as you will ever get. As one of the top 20 pharmaceutical companies in the world this leader in... More »
August 19, 2009 • TEVA, WPI, MYL
The Pros and Cons of Mandated Health Insurance…and How Investors Can Profit by OTC PICKS
The Pros and Cons of Mandated Health Insurance…and How Investors Can Profit It's no secret that health care costs are spiraling out of control in this country. On average, we now spend more per person on health care than both food and housing. Insurance premiums are multiplying... More »
July 21, 2009 • AMED, HUM, JNJ
FDA Calendar Updates: CADX, JNJ, TRGT, WPI by Mike Havrilla
Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 260 entries as of 7/15/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With... More »
July 15, 2009 • CADX, JNJ, TRGT
FDA Calendar Updates: Still Waiting on BDSI by Mike Havrilla
Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 258 entries as of 7/14/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With... More »
July 14, 2009 • BDSI, WPI, MAXY
The Pharmaceutical Industry Gives the Obama Health Care Initiative $80 Billion and Can Come Out with a Bigger Prize—Who are the Winners?? by Larry Rothman
The Obama administration's push to drive healthcare costs down may not be all bad news for the Biopharmaceutical Industry. While the industry today announced/agreed an $80 billion reduction over 10 years ($8 billion/year) in cost reductions to Medicare, they may be able to recoup a... More »
June 22, 2009 • TEVA, NVS, GSK
Four More Ways To Profit From U.S. Healthcare Reform by Smart Profits Report
by Marc Lichtenfeld, Senior Analyst, Smart Profits Report Both President Obama’s and Senator Kennedy’s healthcare plans are estimated to cost $1 trillion over 10 years. I’ll believe it when I see it. When was the last time the government completed any project on budget? For... More »
June 22, 2009 • TEVA, WPI, GENZ
AMAG - Upcoming FDA Decision on Feraheme by Kaushik Paul
AMAG - Upcoming FDA Decision on Feraheme Event Highlights: Event: FDA approval of Feraheme Expectation: Positive Timing: June 29, 2009 Est. Peak Sales/Mkt Cap: 49.08% Licensing Partner: 3SBio Inc. (SSRX) Direct Competitors: The existing intravenous/IV... More »
June 19, 2009 • AMAG, SSRX, WPI

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Watson Pharmaceuticals Inc. (WPI)

Instablog posts on WPI

Best and Worst International ETFs in 2009 by Moby Waller

Kendle International Healthcare by Michael Michaud

Fast Money Final Trade for 9-1-09 by Market Fisher

TEVA: Predictable Growth - Good Value by Chuck Carnevale

The Pros and Cons of Mandated Health Insurance…and How Investors Can Profit by OTC PICKS

FDA Calendar Updates: CADX, JNJ, TRGT, WPI by Mike Havrilla

FDA Calendar Updates: Still Waiting on BDSI by Mike Havrilla

The Pharmaceutical Industry Gives the Obama Health Care Initiative $80 Billion and Can Come Out with a Bigger Prize—Who are the Winners?? by Larry Rothman

Four More Ways To Profit From U.S. Healthcare Reform by Smart Profits Report

AMAG - Upcoming FDA Decision on Feraheme by Kaushik Paul

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers